SecBot SecBot
13FINSTITUTION · CIK 0001493215 · 2026-Q3 · Filed Nov 16, 2026

Rtw Investments

RTW INVESTMENTS, LP
$9.9B
13F long value · 2026-Q3
Positions83
CategoryAsset manager
Quarters tracked10
●#466 of 556 by 13F long value
Size rank 2/10
6NEW6ADD12×+5TRIM3NEAR EXIT5EXIT
Snapshot
Rtw Investments's 13F portfolio at a glance: size, concentration and this quarter's activity.
13F long value
$9.9B
Positions
83
Top 83 long weight
99.8%
Quarters tracked
10
Latest 13F filed
Nov 16, 2026
New positions
6
Exits / near-exits
8
13F long value by quarter
Reported long equity value each quarter: fund flows plus market moves. Option notional is not included.
$6.5B
2024-Q2
$6.9B
2024-Q3
$6.6B
2024-Q4
$6.5B
2025-Q1
$7.0B
2025-Q2
$8.1B
2025-Q3
$10.0B
2025-Q4
$10.0B
2026-Q1
$11.7B
2026-Q2
$9.9B
2026-Q3
Top holdings · 2026-Q3
The fund's largest reported positions. The long positions shown cover 99.8% of the long value.
TickerIssuerWeightValueSharesSince 2026-Q3
PTGX Protagonist Therapeutics, IncProtagonist Therapeutics, Inc7.2%$713.1M5.1M-11.4%
ARGX ARGENX SEARGENX SE6.9%$682.3M711.6K-0.8%
CGON CG Oncology, Inc.CG Oncology, Inc.6.1%$603.6M8.5M+19.6%
IRTC iRhythm Holdings, Inc.iRhythm Holdings, Inc.3.6%$354.5M3.1M-20.1%
INSM INSMED IncINSMED Inc3.6%$353.4M3.1M+7.7%
TNGX Tango Therapeutics, Inc.Tango Therapeutics, Inc.3.5%$350.5M14.0M-3.1%
ERAS Erasca, Inc.Erasca, Inc.3.3%$329.1M22.4M+3.1%
SYRE Spyre Therapeutics, Inc.Spyre Therapeutics, Inc.3.3%$328.7M3.7M+11.6%
RDNT RadNet, Inc.RadNet, Inc.3.2%$319.2M4.6M+11.5%
TARS Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals, Inc.2.8%$273.9M3.5M+0.1%
ZLAB Zai Lab LtdZai Lab Ltd2.7%$272.6M10.4M-10.9%
RGEN REPLIGEN CORPREPLIGEN CORP2.7%$266.3M1.4M-15.3%
GH Guardant Health, Inc.Guardant Health, Inc.2.7%$264.2M1.5M-19.2%
CELC Celcuity Inc.Celcuity Inc.2.6%$262.8M3.3M-23.8%
ORKA Oruka Therapeutics, Inc.Oruka Therapeutics, Inc.2.6%$261.4M3.1M+19.1%
Quarterly changes · 2026-Q3
What Rtw Investments opened, added, trimmed and exited this quarter, largest dollar moves first.
ActionTickerIssuerPrev sharesCurr sharesChangeValue Δ
NEAR EXITMDGL NEAR EXIT MADRIGAL PHARMACEUTICALS, INC. MADRIGAL PHARMACEUTICALS, INC.2.0M312.8K-84.3%-$912.9M
NEAR EXITPTCT NEAR EXIT PTC THERAPEUTICS, INC. PTC THERAPEUTICS, INC.7.7M1.6M-79.1%-$527.2M
TRIMINSM TRIM INSMED Inc INSMED Inc4.8M3.1M-36.1%-$162.9M
ADDZLAB ADD Zai Lab Ltd Zai Lab Ltd6.6M10.4M+57.5%+$147.7M
NEWVRDN NEW Viridian Therapeutics, Inc.\DE Viridian Therapeutics, Inc.\DE04.9MNew+$101.1M
ADDIRTC ADD iRhythm Holdings, Inc. iRhythm Holdings, Inc.2.2M3.1M+42.9%+$94.9M
EXITALKS EXIT Alkermes plc. Alkermes plc.1.7M0-100.0%-$87.6M
TRIMNBIX TRIM NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC1.3M942.7K-25.7%-$80.0M
TRIMCADL TRIM Candel Therapeutics, Inc. Candel Therapeutics, Inc.6.4M3.2M-50.0%-$32.6M
NEWKRSA NEW Korsana Biosciences, Inc. Korsana Biosciences, Inc.0877.0KNew+$28.1M
Conviction over time
Portfolio weight of the current top long holdings, quarter by quarter; rising weight = growing conviction.
PTGX 7.2%
ARGX 6.9%
CGON 6.1%
IRTC 3.6%
INSM 3.6%
TNGX 3.5%
ERAS 3.3%
SYRE 3.3%
RDNT 3.2%
TARS 2.8%